ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Cancer
Fallopian Tube Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Ovarian Cancer trials near Houston, TX, USA:

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and also to find t...

Enrolling
Ovarian Cancer
Platinum Resistant Ovarian Cancer
Biological: OPB-101

Phase 1

Outpace Bio, Inc.

Houston, Texas, United States and 3 other locations

a Phase 1 study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian...

Enrolling
Endometrial Cancer
Metastatic Ovarian Cancer
Drug: ARR-002

Phase 1

ArriVent BioPharma
ArriVent BioPharma

Houston, Texas, United States and 5 other locations

A research study evaluating a new oncolytic virus, THEO-260, in patients with advanced ovarian cancer. The trial will investigate d...

Enrolling
Ovarian Cancer
Biological: THEO-260

Phase 1

Theolytics Limited

Houston, Texas, United States

To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy

Enrolling
Ovarian Cancer
Other: Shared Medical Decision Tool
Behavioral: Engaging Patients in Decision Making
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...

Enrolling
Primary Peritoneal Cancer
Platinum-refractory Ovarian Cancer
Drug: Non-platinum chemotherapy: Physician's Choice of gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin
Drug: Platinum chemotherapy: carboplatin (preferred) or cisplatin

Phase 3

Genelux

Houston, Texas, United States and 32 other locations

To learn if adding lurbinectedin to the combination of paclitaxel and bevacizumab can help to control advanced cancer....

Enrolling
Ovarian Cancer
Drug: Lurbinectedin
Drug: Bevacizumab

Phase 1

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

Ovarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020. The purpos ...

Enrolling
Ovarian Cancer
Drug: Bevacizumab
Drug: Mirvetuximab Soravtansine

Phase 2

AbbVie
AbbVie

The Woodlands, Texas, United States and 83 other locations

the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...

Active, not recruiting
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Cancer
Drug: avutometinib (VS-6766) and defactinib
Drug: avutometinib (VS-6766)

Phase 2

Verastem

The Woodlands, Texas, United States and 46 other locations

combination of NMS-03305293 and topotecan in patients with recurrent ovarian cancer, with dose-limiting toxicity (DLT) escalation. ...

Enrolling
Ovarian Cancer
Drug: NMS-03305293
Drug: Topotecan

Phase 1

Nerviano Medical Sciences

Houston, Texas, United States and 4 other locations

efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...

Active, not recruiting
Fallopian Tube Cancer
Ovarian Cancer
Drug: ONC-392
Drug: Pembrolizumab

Phase 2

OncoC4

The Woodlands, Texas, United States and 20 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems